R. Prasad
@rprasad12
Science journalist with nearly three decades of experience. Ph.D from IIT Bombay @RPrasad12.mstdn.science
ID: 732650840
http://www.journosdiary.com 02-08-2012 11:15:42
25,25K Tweet
9,9K Takipçi
1,1K Takip Edilen
In a trial in South Africa and Uganda, there were zero HIV infections among 2,134 participants who received Lenacapavir PrEP injectable once in six months. Gilead Sciences has licensed four pharma companies in India to make and sell generic Lenacapavir sciencechronicle.in/2025/07/27/len…